Why Do Patients With Systemic Lupus Erythematosus Suffer Pain?

REFERENCES

1. 1.↵
   1. Rees F,
   2. Doherty M,
   3. Grainge M,
   4. Davenport G,
   5. Lanyon P,
   6. Zhang W.

   The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012. Ann Rheum Dis 2016;75:136-41.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Pettersson S,
   2. Lovgren M,
   3. Eriksson LE,
   4. Moberg C,
   5. Svenungsson E,
   6. Gunnarsson I, et al.

   An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol 2012;41:383-90.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Wolfe F,
   2. Ross K,
   3. Anderson J,
   4. Russell IJ,
   5. Hebert L.

   The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Bergman S,
   2. Herrstrom P,
   3. Hogstrom K,
   4. Petersson IF,
   5. Svensson B,
   6. Jacobsson LT.

   Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol 2001;28:1369-77.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Papageorgiou AC,
   2. Silman AJ,
   3. Macfarlane GJ.

   Chronic widespread pain in the population: a seven year follow up study. Ann Rheum Dis 2002;61:1071-4.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. McBeth J,
   2. Macfarlane GJ,
   3. Benjamin S,
   4. Silman AJ.

   Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 2001;44:940-6.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. McBeth J,
   2. Macfarlane GJ,
   3. Hunt IM,
   4. Silman AJ.

   Risk factors for persistent chronic widespread pain: a community-based study. Rheumatology 2001;40:95-101.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Foster NE,
   2. Pincus T,
   3. Underwood MR,
   4. Vogel S,
   5. Breen A,
   6. Harding G.

   Understanding the process of care for musculoskeletal conditions--why a biomedical approach is inadequate. Rheumatology 2003;42:401-4.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Karlson EW,
   2. Daltroy LH,
   3. Rivest C,
   4. Ramsey-Goldman R,
   5. Wright EA,
   6. Partridge AJ, et al.

   Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003; 12:280-6.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Yazdany J,
    2. Trupin L,
    3. Gansky SA,
    4. Dall’era M,
    5. Yelin EH,
    6. Criswell LA, et al.

    Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus. Arthritis Care Res 2011;63:1170-7.

    OpenUrl
11. 11.↵
    1. Falasinnu T,
    2. Drenkard C,
    3. Bao G,
    4. Mackey S,
    5. Lim SS.

    The problem of pain in lupus: an explication of the role of biopsychosocial mechanisms. J Rheumatol 2021;48:1279-89.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Waldheim E,
    2. Elkan AC,
    3. Pettersson S,
    4. van Vollenhoven R,
    5. Bergman S,
    6. Frostegard J, et al.

    Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain. Lupus 2013;22:1118-27.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Vincent A,
    2. Lahr BD,
    3. Wolfe F,
    4. Clauw DJ,
    5. Whipple MO,
    6. Oh TH, et al.

    Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res 2013;65:786-92.

    OpenUrlCrossRef
14. 14.↵
    1. Wolfe F,
    2. Clauw DJ,
    3. Fitzcharles MA,
    4. Goldenberg DL,
    5. Hauser W,
    6. Katz RS, et al.

    Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011;38:1113-22.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Wolfe F,
    2. Clauw DJ,
    3. Fitzcharles MA,
    4. Goldenberg DL,
    5. Katz RS,
    6. Mease P, et al.

    The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600-10.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Sutton EJ,
    2. Davidson JE,
    3. Bruce IN.

    The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review. Semin Arthritis Rheum 2013;43:352-61.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Taylor SJ,
    2. Carnes D,
    3. Homer K,
    4. Kahan BC,
    5. Hounsome N,
    6. Eldridge S, et al.

    Novel three-day, community-based, nonpharmacological group intervention for Chronic Musculoskeletal Pain (COPERS): a randomised clinical trial. PLoS Med 2016;13:e1002040.

    OpenUrlCrossRefPubMed